Abstract:
The present invention provides a novel family of apoptosis-modulating proteins. Nucleotide and amino acid residue sequences and methods of use thereof are also provided.
Abstract:
A load-absorbing device initiates load forces such as cable forces or tensioning forces of sheet-shaped structures into supporting structures (10). At least one bearing element (24, 80) is anchored on supporting structure (10). A tie rod (40) of a load-absorbing part (36, 40) is connected to the bearing element. A connection device (50) for tension members (16; 98) cooperates with the tie bar (40). The connection device (50) has at least one connection wing (66) projecting laterally from the longitudinal axis (A) and forming at least one connection point (69a) offset with respect to the longitudinal axis (A).
Abstract:
A method of determining and shifting to an optimal gear in a vehicle prior to entering a curve in a vehicle which comprises an automatic transmission. A curve speed limit is determined for an anticipated curve which is recognized by a navigation device, an anticipated road pattern and dependent on the vehicle and curve or road data, and a sportiness indicator (Ftyp). For each anticipated curve, an actual, optimal gear is determined, based on the determined curve speed limit and the sportiness indicator (FTyp) and, after determinating the optimal gear, the method performs a check to determine whether or not the optimal gear deviates from the engaged gear (RGA_DEST). When a deviation is recognized and a driver reaction, which causes a deceleration of the vehicle and/or a reduction of the vehicle speed, is present, a down shift down to the actual, optimal gear occurs.
Abstract:
Methods and apparatus for recovering hydrogen fluoride (HF) are provided herein. In some embodiments, an apparatus includes a system for processing substrates, including a process chamber for processing a substrate; a fluorine generator coupled to the process chamber to provide fluorine (F2) thereto; an abatement system coupled to the process chamber to abate fluorine-containing effluents exhausted from the process chamber and to convert at least a portion of the fluorine-containing effluents into hydrogen fluoride (HF); an HF recovery system configured to at least one of collect, purify, or concentrate the HF converted by the abatement system; and a conduit for providing the recovered hydrogen fluoride (HF) to the fluorine generator or another application in the manufacturing process.
Abstract:
A method for the control of a controllable aggregate, in particular a transmission of a motor vehicle, in which to form at least one determinant magnitude various or varying numbers of contributions from delivery objects are taken into account, at least two different delivery objects being provided, by way of which respective contributions for the determination of the determinant magnitude are determined and such that a counter is provided, to which the contributions by all the delivery objects are sent. The counter evaluates each contribution by way of a weighting and sends it to an evaluating mechanism and this evaluating mechanism determines the determinant magnitude from the evaluated contributions. In addition, the invention concerns a control unit for the control of a controllable aggregate in accordance with such a method and an aggregate with such a control unit.
Abstract:
The invention concerns genes and gene sets and methods useful in the prediction of the response of a cancer patient to treatment with an epidermal growth factor receptor (EGFR) inhibitor.
Abstract:
The present invention provides a novel family of apoptosis-modulating proteins. Nucleotide and amino acid residue sequences and methods of use thereof are also provided.
Abstract:
The invention concerns sensitive methods to measure mRNA levels in biopsied tumor tissues, including archived paraffin-embedded biopsy material. Th invention also concerns breast cancer gene sets important in the diagnosis and treatment of breast cancer, and methods for assigning the most optimal treatment options to breast cancer patient based upon knowledge derived from gene expression studies.